Pfizer and Sangamo Announce Updated Phase 1/2 Results
Pfizer and Sangamo Therapeutics announced updated follow-up data from the Phase 12 Alta study of giroctocogene fitelparvovec, an investigational gene...
International Stem Cell Wraps First Round of Parkinson's Disease Trial
International Stem Cell announced that the final patient in a clinical trial for Parkinson's Disease was successfully transplanted with ISC-hpNSC...
uniQure Receives PRIME Designation in Europe
uniQure announced their gene therapy AMT-060, received PRIME designation from the European Medicines Agency.
uniQure Won't Apply for Marketing Renewal of Glybera
uniQure N.V. announced it won't seek a marketing authorization renewal for Glybera in the European market, which is set to...
Cytori Gets Green Light for Thermal Burn Clinical Trial
Cytori Therapeutics received approval from the US Food and Drug Administration for a burn clinical trial using the Cytori Cell...
Cytori Announces Proposed Public Offering of Common Stock
Cytori Therapeutics announced it plans to offer a public offering of common stock in order to fund the HABEO and...
Myriad Genetics Launches Collaboration With BeiGene
Myriad Genetics announced a diagnostic development collaboration with BeiGene a company developing molecularly-targeted and immuno-oncology drugs for the treatment of...